Mounjaro in Northern Ireland: what you actually need to know

The misconception that puts people off before they even start

A surprising number of people in Northern Ireland assume Mounjaro simply isn't available to them — that it's an England-only rollout, or that geography places it out of reach. That belief is understandable, given how patchy early coverage was, but it no longer holds. UK marketing authorisation covers all four nations, which means the medicine itself is fully licensed here. What differs is how NHS access works locally, and that's worth separating from the question of whether you can access treatment at all.

The NHS route in Northern Ireland is tied to commissioning decisions by regional health bodies, which may lag behind or differ from NHS England's phased schedule. That phasing doesn't affect private prescriptions. A GPhC-registered prescriber can assess anyone in the UK, including Northern Ireland, and prescribe tirzepatide privately if it's clinically appropriate. Worth knowing before you write the option off.

There is also a quieter misconception worth letting go gently: that online prescribing is somehow less rigorous than a GP appointment. A properly regulated service involves identity checks, weight verification, a review of your medical history, and a qualified prescriber reading your answers on the same day — the same clinical gate, delivered differently. How nume approaches this is set out on our about page if you'd like to see the specifics.

NHS access in Northern Ireland: what the NICE guidance actually says

NICE published its recommendation for tirzepatide (TA1026) in December 2024, updated in September 2025. The guidance recommends tirzepatide for adults with a BMI of 35 or above plus at least one weight-related comorbidity, conditions that include high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes. Lower BMI thresholds apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, where the adjustment is 2.5 kg/m².

NHS England's phased rollout opened to patients with a BMI of 40 or above and four or more of those qualifying conditions from June 2025, with a second cohort covering BMI 35–39.9 with four or more conditions from June 2026. Northern Ireland commissions healthcare separately, so local availability through NHS services may differ from these English timelines. The NICE TA1026 guidance sets the clinical standard, but commissioning implementation is a devolved matter. If you're uncertain about your NHS eligibility locally, your GP surgery is the right first call.

For people who don't meet the current NHS criteria, or who prefer not to wait, a private prescription through a regulated online pharmacy is available now, with no referral required. The clinical criteria for private prescribing follow the licensed indications in the SmPC: BMI of 30 or above, or 27 or above alongside a relevant weight-related condition.

What starting Mounjaro actually involves, wherever you are

Treatment begins at 2.5mg, a dose chosen to let your body adjust, not to produce immediate weight loss. From there, a prescriber typically increases the dose in 4-week steps through the available strengths (5mg, 7.5mg, 10mg, 12.5mg and 15mg), according to how you're tolerating each level. The 2.5mg starting pen and the 5mg pen are the first two rungs on that schedule.

Mounjaro is a once-weekly subcutaneous injection, given via a pre-filled KwikPen into the abdomen, thigh or upper arm; you rotate sites each week. Common side effects are mostly gastrointestinal: nausea, loose stools, constipation and indigestion are the ones most frequently reported, especially in the early weeks after starting or after a dose increase. They typically settle, though how quickly varies. The NHS patient information for tirzepatide covers these in detail, including which symptoms should prompt you to contact a prescriber sooner rather than later.

If you're on the oral contraceptive pill, tirzepatide's effect on gastric emptying can temporarily reduce how well it's absorbed. NHS guidance recommends adding a non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase. There's a fuller explanation on the Mounjaro and the mini pill page if that's relevant to you.

Private prescribing from Northern Ireland: the practical route

Accessing Mounjaro privately from Northern Ireland follows the same process as anywhere else in the UK. You complete a free online consultation, a GPhC-registered prescriber reviews it and, if clinically appropriate, issues a prescription the same day. Delivery is free and next-working-day by DPD, tracked and in plain packaging, to any address in Northern Ireland. Orders placed before noon on a working day are dispatched the same day once approved.

Before using any online pharmacy, it takes about thirty seconds to confirm they're legitimate: the GPhC maintains a public register of all registered pharmacies at pharmacyregulation.org/registers. Sellers offering Mounjaro without a valid prescription, or at prices well below the market range, are a serious concern; the MHRA has warned repeatedly about counterfeit weight-loss pens and has made significant seizures of illegally traded stock. If a price looks too good and there's no prescriber involved, that's a red flag, not a bargain.

There is a cost to private treatment, and it varies by dose and provider. The Mounjaro pricing page explains what to expect and what a legitimate price should include. If you'd like to explore whether treatment is appropriate for your situation, checking your eligibility starts with a free consultation.